3.72
price down icon2.11%   -0.08
 
loading
Elutia Inc stock is traded at $3.72, with a volume of 60,855. It is down -2.11% in the last 24 hours and down -1.85% over the past month. Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$3.80
Open:
$3.79
24h Volume:
60,855
Relative Volume:
1.46
Market Cap:
$129.43M
Revenue:
$35.35M
Net Income/Loss:
$-37.66M
P/E Ratio:
-1.6533
EPS:
-2.25
Net Cash Flow:
$-22.11M
1W Performance:
+12.73%
1M Performance:
-1.85%
6M Performance:
+26.96%
1Y Performance:
+171.53%
1-Day Range:
Value
$3.715
$3.81
1-Week Range:
Value
$3.1201
$3.88
52-Week Range:
Value
$1.33
$5.24

Elutia Inc Stock (ELUT) Company Profile

Name
Name
Elutia Inc
Name
Phone
240-247-1143
Name
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-11-14
Name
Latest SEC Filings
Name
ELUT's Discussions on Twitter

Elutia Inc Stock (ELUT) Latest News

pulisher
Nov 01, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Rises By 7.4% - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024 - The Manila Times

Oct 29, 2024
pulisher
Oct 24, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - The Manila Times

Oct 24, 2024
pulisher
Oct 22, 2024

Individual investors among Elutia Inc.'s (NASDAQ:ELUT) largest stockholders and were hit after last week's 10% price drop - Simply Wall St

Oct 22, 2024
pulisher
Oct 15, 2024

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc - GuruFocus.com

Oct 15, 2024
pulisher
Oct 10, 2024

Preclinical Data Show Efficacy Of Elutia's Antibiotic-Eluting BioEnvelope - MPO-mag

Oct 10, 2024
pulisher
Oct 04, 2024

Elutia (NASDAQ:ELUT) vs. Curis (NASDAQ:CRIS) Head to Head Comparison - Defense World

Oct 04, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Purchases 145,697 Shares of Elutia Inc. (NASDAQ:ELUT) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1% - MarketBeat

Sep 28, 2024
pulisher
Sep 18, 2024

Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices - StockTitan

Sep 18, 2024
pulisher
Sep 17, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9% - MarketBeat

Sep 17, 2024
pulisher
Sep 12, 2024

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - HMP Global Learning Network

Sep 12, 2024
pulisher
Sep 11, 2024

Elutia announces first patient implant of EluPro, the world’s first drug-eluting bioenvelope for cardiac pacemakers and neurostimulators - Cardiovascular Business

Sep 11, 2024
pulisher
Sep 09, 2024

AIGH Capital Management LLC Increases Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat

Sep 09, 2024
pulisher
Sep 08, 2024

Cantor Fitzgerald Reiterates “Overweight” Rating for Elutia (NASDAQ:ELUT) - Defense World

Sep 08, 2024
pulisher
Sep 06, 2024

Elutia Celebrates First Year - ForexTV.com

Sep 06, 2024
pulisher
Sep 06, 2024

Elutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 06, 2024
pulisher
Sep 05, 2024

Elutia Announces First Patient Implant of EluPro™, the - GlobeNewswire

Sep 05, 2024
pulisher
Sep 03, 2024

Elutia to Participate in Upcoming Investor Conferences - ForexTV.com

Sep 03, 2024
pulisher
Aug 31, 2024

Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution

Aug 31, 2024
pulisher
Aug 29, 2024

Ryan Marques Joins Elutia As VP Of Operations - MPO-mag

Aug 29, 2024
pulisher
Aug 29, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Expands By 468.3% - Defense World

Aug 29, 2024
pulisher
Aug 29, 2024

Ryan Marques Joins Elutia as VP of Operations - MPO-mag

Aug 29, 2024
pulisher
Aug 27, 2024

Elutia Inc. (NASDAQ:ELUT) Short Interest Update - MarketBeat

Aug 27, 2024
pulisher
Aug 21, 2024

Spine Implant Caused Patient's TB, Suit Says - Law360

Aug 21, 2024
pulisher
Aug 19, 2024

ELUT (Elutia) Financial Strength : 2 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 16, 2024

ELUT (Elutia) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 10, 2024

Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 10, 2024
pulisher
Aug 08, 2024

Elutia (NASDAQ:ELUT) Price Target Cut to $10.00 - MarketBeat

Aug 08, 2024
pulisher
Aug 08, 2024

Elutia Wins FDA Clearance Of Its Antibiotic-Eluting BioEnvelope - MPO-mag

Aug 08, 2024
pulisher
Aug 07, 2024

Elutia Announces Second Quarter 2024 Results - StockTitan

Aug 07, 2024
pulisher
Aug 05, 2024

Elutia (ELUT) Set to Announce Earnings on Wednesday - Defense World

Aug 05, 2024
pulisher
Aug 01, 2024

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds - StockTitan

Aug 01, 2024
pulisher
Aug 01, 2024

Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year? - Yahoo Finance

Aug 01, 2024
pulisher
Aug 01, 2024

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations - citybiz

Aug 01, 2024
pulisher
Jul 31, 2024

BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family - Diagnostic and Interventional Cardiology

Jul 31, 2024
pulisher
Jul 31, 2024

ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan

Jul 31, 2024
pulisher
Jul 26, 2024

Elutia Inc. (NASDAQ:ELUT) Sees Significant Drop in Short Interest - MarketBeat

Jul 26, 2024
pulisher
Jul 26, 2024

Elutia Inc. (NASDAQ:ELUT) Sees Large Drop in Short Interest - Defense World

Jul 26, 2024
pulisher
Jul 22, 2024

Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus - MSN

Jul 22, 2024
pulisher
Jul 17, 2024

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire

Jul 17, 2024
pulisher
Jul 13, 2024

Elutia Inc. (NASDAQ:ELUT) Short Interest Up 1,408.3% in June - Defense World

Jul 13, 2024
pulisher
Jul 12, 2024

7 Growth Stocks to Buy for Under $5 for Massive Gains - InvestorPlace

Jul 12, 2024
pulisher
Jul 11, 2024

Elutia Inc. (NASDAQ:ELUT) Sees Significant Growth in Short Interest - MarketBeat

Jul 11, 2024
pulisher
Jul 11, 2024

Elutia to Present at the Emerging Growth Conference on Thursday, July 18 - StockTitan

Jul 11, 2024

Elutia Inc Stock (ELUT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Elutia Inc Stock (ELUT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Ferguson Matthew
CHIEF FINANCIAL OFFICER
Mar 08 '24
Option Exercise
0.00
1,288
0
121,807
medical_devices ZBH
$107.81
price down icon 0.55%
medical_devices STE
$227.18
price up icon 0.53%
medical_devices PHG
$27.11
price up icon 0.13%
$68.67
price down icon 0.80%
$87.08
price up icon 0.09%
medical_devices EW
$66.50
price down icon 0.06%
Cap:     |  Volume (24h):